DHTKD1 and neoplasm: We developed a telomerase-specific replication-competent oncolytic adenovirus, OBP-301 (Telomelysin), in which the tumor-specific hTERT promoter regulates the expression of the adenoviral E1A and E1B genes [17] (Figure 1).